Business Description
TherapeuticsMD Inc
NAICS : 325412
SIC : 2834
ISIN : US88338N1072
Description
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.64 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Interest Coverage | 21.57 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -27.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.5 | |||||
| 3-Year FCF Growth Rate | 76.9 | |||||
| 3-Year Book Growth Rate | 29.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.82 | |||||
| 9-Day RSI | 21.08 | |||||
| 14-Day RSI | 25.58 | |||||
| 6-1 Month Momentum % | 12.94 | |||||
| 12-1 Month Momentum % | -39.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.37 | |||||
| Quick Ratio | 1.37 | |||||
| Cash Ratio | 0.96 | |||||
| Days Sales Outstanding | 601.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.5 | |||||
| Shareholder Yield % | 330.74 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 135.79 | |||||
| Operating Margin % | 220.72 | |||||
| Net Margin % | 186.37 | |||||
| ROE % | 889 | |||||
| ROA % | 44.15 | |||||
| ROIC % | 56.65 | |||||
| ROC (Joel Greenblatt) % | -834.69 | |||||
| ROCE % | -508.83 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.67 | |||||
| Price-to-Owner-Earnings | 1.43 | |||||
| PS Ratio | 1.23 | |||||
| PB Ratio | 1.02 | |||||
| Price-to-Tangible-Book | 1.3 | |||||
| Price-to-Free-Cash-Flow | 1.45 | |||||
| Price-to-Operating-Cash-Flow | 1.45 | |||||
| EV-to-EBIT | -0.41 | |||||
| EV-to-EBITDA | -0.43 | |||||
| EV-to-Revenue | 1.19 | |||||
| EV-to-Forward-Revenue | 0.95 | |||||
| EV-to-FCF | 1.3 | |||||
| Earnings Yield (Greenblatt) % | -243.9 | |||||
| Forward Rate of Return (Yacktman) % | 14097.15 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TXMD
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TherapeuticsMD Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 22.922 | ||
| EPS (TTM) ($) | 4.49 | ||
| Beta | -0.02 | ||
| Volatility % | 56.36 | ||
| 14-Day RSI | 25.58 | ||
| 14-Day ATR ($) | 0.171811 | ||
| 20-Day SMA ($) | 3.618 | ||
| 12-1 Month Momentum % | -39.53 | ||
| 52-Week Range ($) | 2.94 - 7.5299 | ||
| Shares Outstanding (Mil) | 10.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TherapeuticsMD Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TherapeuticsMD Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
TherapeuticsMD Inc Frequently Asked Questions
What is TherapeuticsMD Inc(TXMD)'s stock price today?
The current price of TXMD is $3.01. The 52 week high of TXMD is $7.53 and 52 week low is $2.94.
When is next earnings date of TherapeuticsMD Inc(TXMD)?
The next earnings date of TherapeuticsMD Inc(TXMD) is 2023-11-14 Est..
Does TherapeuticsMD Inc(TXMD) pay dividends? If so, how much?
TherapeuticsMD Inc(TXMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers